ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020

Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.

Mei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.